Abnormal Newborn Screening Results and Additional Testing
If your baby’s newborn screening results are abnormal, your baby will need to have another test. Not every abnormal result means your baby has a disorder. It is important to have quick follow-up testing. Without treatment, SCAD Deficiency can result in harmful effects soon after birth.
The Utah Newborn Screening Program will contact you and your child’s pediatrician for blood and urine testing.
The Metabolic Clinic at Primary Children’s Hospital cares for babies diagnosed with SCAD Deficiency.
About SCAD Deficiency
SCAD Deficiency is a fatty acid oxidation disorder. People affected by SCAD Deficiency are not able to break down certain fats from food for the energy their body requires.
If untreated, SCAD Deficiency can cause learning delays, liver trouble, and muscle weakness. However, if the condition is detected early, proper treatment may help improve the symptoms of SCAD Deficiency.
Frequency
SCAD Deficiency is estimated to affect 1 in 40,000 to 1 in 100,000 babies in the United States.
Condition Type
SCAD Deficiency is a Fatty Acid Oxidation Disorder.
Also Known As
SCADD, SCADH Deficiency, ACADS Deficiency, Short-Chain Acyl-CoA Dehydrogenase Deficiency, Short-Chain Acyl-Coenzyme A Dehydrogenase Deficiency, Lipid-Storage Myopathy Secondary to Short-Chain Acyl-CoA Dehydrogenase Deficiency, C4
More Information
For Parents
- Baby’s First Test opens in a new tab
- Star-G Parents’ Fact Sheet opens in a new tab
- Medical Home Portal opens in a new tab
For Physicians
- ACMG ACT Sheet opens in a new tab
- Genetics Home Reference opens in a new tab
- SCAD Protocol opens in a new tab (New England Consortium of Metabolic Programs)